Scinai Immunotherapeutics Shares Resume Trade
Portfolio Pulse from Benzinga Newsdesk
Scinai Immunotherapeutics shares have resumed trading after a temporary halt.
July 15, 2024 | 1:40 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Scinai Immunotherapeutics shares have resumed trading after a temporary halt, which could lead to increased volatility in the short term.
The resumption of trading after a halt often leads to increased volatility as investors react to the news. However, without additional context on why the halt occurred, the short-term price direction remains neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100